Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Communication Strategies. Case Studies. Applied Knowledge.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 07 May 2012
China's State Food and Drug Administration has further expanded its international collaborative efforts in regulatory matters by concluding a Memorandum of Understanding (MOU) with the Ministry of Health of the Netherlands.
The new MOU calls for expanded cooperation between the two countries on matters relating to the regulation of drugs and medical devices.
A Dutch company had exported to China breast implants containing industrial grade silicone that were supplied by the French manufacturer of the faulty implants, Poly Implant Prothese (PIP).
Read more:Discipline inspection group leader 中央纪委驻 Bureau Yin into access to the Netherlands Institute for Health Supervision Bureau and the signing of the Memorandum of Understanding - China's State Food and Drug Administration
Tags: breast implants, MOU, Netherlands, PIP